Fundraising FoxPerseus Proteomics
5 known investors
Find your way into Perseus Proteomics
Sign up to see every warm intro you have to Perseus Proteomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Perseus Proteomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development. The company provides approximately 100 antibody products including anti-ERβ antibodies established as the gold standard for ERβ research, as well as specialized antibodies for drug-antibody conjugates and radioimmunoterapy applications.
Investors · 5
How we know: Kyoto University Innovation Capital's portfolio page · Not right? Tell us
How we know: Newton Biocapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Perseus Proteomics do?
- Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development. The company provides approximately 100 antibody products including anti-ERβ antibodies established as the gold standard for ERβ research, as well as specialized antibodies for drug-antibody conjugates and radioimmunoterapy applications.
- Who are Perseus Proteomics's investors?
- Perseus Proteomics's investors include DBJ Capital, Kyoto University Innovation Capital, Newton Biocapital, Nippon Venture Capital, SMBC Venture Capital.